Urticaria is an inflammatory skin disorder that affects up to 20% of the world population at
some point during their life. It presents with wheals, angioedema or both due to activation …

Chronic urticaria (CU) is a mast cell-driven chronic inflammatory disease with a female
predominance. Since CU affects mostly females in reproductive age, pregnancy is an …

Abstract Background Chronic inducible urticaria (CIndU) is characterized by mast cell (MC)‐
mediated wheals in response to triggers: cold in cold urticaria (ColdU) and friction in …

Background Chronic spontaneous urticaria (CSU) is inadequately controlled in many
patients and greatly affects quality of life. Remibrutinib, a highly selective, oral, novel …

Background In chronic spontaneous urticaria (CSU), the guidelines recommend very limited
diagnostic procedures during the routine workup, although additional investigations might …

Importance Chronic spontaneous urticaria affects approximately 1% of the general
population worldwide, including approximately 3 million people in the US, impairs patients' …

Abstract Purpose of Review Chronic inducible urticaria (CIndU) is a group of long-persisting
and challenging to manage diseases, characterized by recurrent wheals and angioedema …

Chronic Urticaria (CU) is a chronic inflammatory, predominantly mast cell-driven disease,
characterized by the development of wheals and/or angioedema for more than 6 weeks. It …

Background Patients with chronic spontaneous urticaria (CSU) can have comorbid inducible
urticaria (CIndU). How comorbid CIndU affects patients and their CSU is largely unclear …

Background Remibrutinib (LOU064), an oral, highly selective Bruton tyrosine kinase
inhibitor, offers fast disease control in patients with chronic spontaneous urticaria (CSU) who …